What is the recommended timing for discontinuing acenocoumarol and reversing its anticoagulant effect before emergency orthopedic surgery?

Acenocoumarol Timing Before Emergency Orthopedic Surgery

For emergency orthopedic surgery, acenocoumarol should be discontinued 2-3 days before the procedure with a target INR ≤1.2, which is significantly shorter than the 5-day interruption required for warfarin. 1

Preoperative Discontinuation Timeline

The most recent French guidelines (2025) provide explicit timing for acenocoumarol that differs substantially from warfarin:

• Acenocoumarol: 3 days before neuraxial procedures (which have similar bleeding risk to orthopedic surgery) with target INR ≤1.2 1
• This contrasts with warfarin's 5-day interruption requirement 2, 1

The shorter interruption period for acenocoumarol reflects its shorter half-life compared to warfarin, allowing faster clearance and INR normalization.

Key Implementation Points

Verify INR Before Surgery

• Target INR: ≤1.2 for safe surgical hemostasis 1
• If INR remains >1.2 after the 2-3 day interruption, consider:
  • Measuring residual anticoagulation levels
  • Administering vitamin K for reversal
  • Using prothrombin complex concentrates (PCC) in true emergencies

Special Populations Requiring Longer Interruption

The 2022 CHEST guidelines note that certain patients may need extended interruption periods 2:

• Elderly patients with comorbidities
• Patients requiring very low acenocoumarol doses (suggesting enhanced sensitivity)
• Those with higher baseline target INR ranges
• Patients with renal impairment (acenocoumarol dose requirements correlate with eGFR) 3

Emergency Reversal Considerations

For truly urgent surgery where 2-3 days is too long:

1. Immediate reversal agents should be administered if surgery cannot be delayed 1
2. Vitamin K (5-10 mg IV) begins working within 6-12 hours
3. Prothrombin complex concentrates (PCC) provide immediate reversal for life-threatening situations
4. Do not delay life-saving surgery for INR normalization—use reversal agents and proceed

Postoperative Resumption

Resume acenocoumarol 24-72 hours postoperatively once adequate surgical hemostasis is achieved 2, 1:

• For high bleeding risk procedures: 24-72 hours post-op 1
• For low bleeding risk procedures: Resume at usual schedule, minimum 6 hours after procedure 1
• Bridge with prophylactic-dose LMWH until therapeutic INR is re-established 1

Critical Timing Note

Acenocoumarol requires 2-3 days for partial anticoagulant effect and 4-8 days for full therapeutic effect after resumption 2, so bridging anticoagulation is essential in high-risk patients.

Common Pitfalls to Avoid

1. Do not use warfarin timing (5 days) for acenocoumarol—this causes unnecessary delay and increases thromboembolic risk
2. Do not skip INR verification before surgery, especially in elderly or renally impaired patients who may have prolonged drug effects
3. Do not resume full-dose acenocoumarol immediately post-op without confirming adequate hemostasis
4. Do not forget bridging anticoagulation in high thromboembolic risk patients (recent VTE <3 months, mechanical valves, high-risk AF) 1

Risk Stratification for Bridging

Consider temporary vena cava filter placement if 1:

• Surgery required <1 month after proximal DVT/PE (strong recommendation)
• Surgery 1-3 months after VTE AND therapeutic anticoagulation cannot resume within 72 hours post-op

This approach balances the competing risks of perioperative bleeding against thromboembolic events, with acenocoumarol's pharmacokinetics allowing a more streamlined interruption protocol than warfarin.